Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19521275)

  • 1. Lack of utility of CD20 immunohistochemistry in staging bone marrow biopsies for diffuse large B-cell lymphoma.
    Baiyee D; Warnke R; Natkunam Y
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):93-5. PubMed ID: 19521275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma: morphologic and immunohistochemical analysis of bone marrow for staging, with emphasis on lymphoid aggregates.
    Nóbrega VC; Domingues MAC; Niero-Melo L; Oliveira CC
    Int J Clin Exp Pathol; 2022; 15(9):345-353. PubMed ID: 36237636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.
    Palacio C; Acebedo G; Navarrete M; Ruiz-Marcellán C; Sanchez C; Blanco A; López A
    Haematologica; 2001 Sep; 86(9):934-40. PubMed ID: 11532621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
    Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL).
    Talaulikar D; Dahlstrom JE; Shadbolt B; Broomfield A; McDonald A
    J Histochem Cytochem; 2008 Oct; 56(10):893-900. PubMed ID: 18574254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.
    Won D; Park CJ; Shim H; Jang S; Chi HS; Huh J; Yoon DH; Suh C
    Histopathology; 2013 Feb; 62(3):397-405. PubMed ID: 23163529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
    Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
    Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
    Chu PG; Loera S; Huang Q; Weiss LM
    Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).
    Talaulikar D; Shadbolt B; Dahlstrom JE; McDonald A
    J Hematol Oncol; 2009 Nov; 2():49. PubMed ID: 19930611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
    Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report.
    Ding C; Huang Y; Shi M; Nie B; Li Y; Wu K; Yang J; Zeng Y
    Medicine (Baltimore); 2019 Apr; 98(15):e15204. PubMed ID: 30985716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of concordant and discordant cytomorphology of bone marrow involvement in patients with diffuse, large, B-cell lymphoma treated with R-CHOP.
    Shim H; Oh JI; Park SH; Jang S; Park CJ; Huh J; Suh C; Chi HS
    J Clin Pathol; 2013 May; 66(5):420-5. PubMed ID: 23610041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.
    Rasheed AA; Samad A; Raheem A; Hirani SI; Shabbir- Moosajee M
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):331-335. PubMed ID: 29479962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
    Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma.
    Tsirigotis P; Economopoulos T; Rontogianni D; Dervenoulas J; Papageorgiou E; Bollas G; Mantzios G; Kalantzis D; Koumarianou A; Raptis S
    Oncology; 2001; 61(4):257-64. PubMed ID: 11721171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathologic and immunohistochemical study of diffuse large B-cell lymphoma.
    Tao K; Zhu X; Xu W; Chen Z; Lu H
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):112-5. PubMed ID: 12419155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
    Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
    Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma of the breast. A clinicopathologic study of primary and secondary cases.
    Topalovski M; Crisan D; Mattson JC
    Arch Pathol Lab Med; 1999 Dec; 123(12):1208-18. PubMed ID: 10583925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of monoclonal immunoglobulin gene rearrangement in conjunction with histologic B-cell aggregates in the bone marrow of patients with diffuse large B-cell lymphoma.
    Cho YA; Yang WI; Song JW; Min YH; Yoon SO
    Cancer Med; 2016 Jun; 5(6):1066-73. PubMed ID: 26923640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type.
    Tierens AM; Holte H; Warsame A; Ikonomou IM; Wang J; Chan WC; Delabie J
    Haematologica; 2010 Aug; 95(8):1334-41. PubMed ID: 20145271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.